ntr123-C_202401645EN.000101-E0123
COMMUNICATION FROM THE COMMISSION Commission Notice on the definition of the relevant market for the purposes of Union competition law · European Union
(123) In particular in the pharmaceutical industry, the Commission has considered in previous cases that the geographic scope of the market was global or at least EEA-wide, to the extent that R&D for the relevant pipeline products is at least EEA-wide. See, for example cases M.7275 Novartis/GSK Oncology Business, paragraph 32 and M.7480 Actavis/Allergan, paragraph 17.
Source: EUR-Lex (Cellar) · retrieved 2026-09-25 · Text as adopted (Official Journal); later amendments are not incorporated in this text.